D9612 Dental Code: Multiple Therapeutic Injections

What D9612 covers

D9612 reports two or more administrations of different therapeutic medications given parenterally at one dental visit. A steroid to control swelling plus an antibiotic for an active infection. An antiemetic for nausea plus an anti-inflammatory for pain. The drugs are treating clinical problems, and there are at least two of them.

D9610 is the single-administration version of the same service and sets out what “therapeutic” excludes. This page is about the part that generates the denials, which is the count.

Parenteral is broader than most billers assume. Carrier policy defines it as any route that bypasses the gastrointestinal tract, which covers intramuscular, intravenous, subcutaneous, submucosal, intraosseous, and intranasal delivery. A drug given intranasally counts. A pill the patient swallows does not.

The distinguishing axis: distinct drugs, counted per visit

D9612 turns on one number, and it is the number of chemically distinct medications administered during the appointment. Three things that look like they should raise the count do not:

• Repeat doses of one drug. A second push of the same steroid is a second administration of the same medication. The distinct-drug count is still one.
• Multiple injection sites. One antibiotic infiltrated in three places is one drug.
• Multiple routes for one drug. The same medication given IM and then IV is still one medication.

So the decision at the chair runs like this. Count the distinct drug names on the medication log for that date. One name means D9610. Two or more names means D9612, reported once for the visit regardless of whether it was two drugs or four.

Repeat dosing of one drug is the case that leaves practices without a clean answer. CDT publishes no code for a second administration of the same medication, so the options are to report one unit of D9610 for the visit or to attempt a second unit. Plans split on this, and plenty of them treat the appointment as one administration event whatever the dosing looked like. Verify the specific plan’s position rather than assuming quantity two will process.

What D9612 is not

Three exclusions do most of the damage on this code. The first is written into the CDT descriptor itself; the other two follow from the code definitions and from carrier policy.

It is not sedation. Therapeutic drug administration explicitly excludes sedatives, anesthetics, and reversal agents. Sedation is billed from its own time-based family, including D9239 and D9243 for intravenous moderate sedation and D9222 and D9223 for deep sedation and general anesthesia. Carrier policies for therapeutic drugs also rule out administrations given routinely or as part of a general anesthesia, analgesia, sedation, or premedication protocol, which closes the door on treating the agents in a sedation cocktail as two therapeutic drugs.

It is not local anesthesia. Numbing the patient is D9210 or D9215 depending on whether a procedure was done that day, and D9215 is bundled into the procedure fee almost every time. A long-acting agent infiltrated for post-surgical pain control has its own code, D9613, reported per quadrant. That one is worth flagging separately, since at least one national carrier takes the position that sustained-release infiltration is not indicated at all on the current evidence and denies it as a matter of policy.

It is not medication sent home. D9630 reports drugs or medicaments dispensed in the office for the patient to use at home. Handing a patient a course of oral antibiotics and a fluoride rinse is two products, and it is still D9630 rather than D9612, because nothing was administered chairside.

Why the claim gets denied

Denials on D9612 cluster into four patterns, and only the first one is really about the count:

1. The chart shows one drug. The claim says two or more medications, the medication log names one, and the line reverses on review. This is the audit finding that shows up most often.
2. The plan carries no benefit. Some plans exclude therapeutic drug administration outright as a covered service, so the denial has nothing to do with the documentation. Fee schedules that list D9610 through D9630 as non-covered are common enough that it is worth checking before the visit.
3. The plan bundles it into the same-day procedure. If the drugs supported a surgical extraction, some plans consider the administration part of that procedure’s fee.
4. The clinical reason is missing. Carrier criteria for these codes generally require an unusual circumstance or an existing infection or inflammation, and rule out administration given to prevent an infection that has not appeared yet. A note that reads “antibiotic given post-op” without a diagnosis reads as prophylaxis, which several policies exclude by name.

None of this is universal. Coverage on therapeutic drug administration varies more between plans than almost anything else in the adjunctive category, so verify the specific benefit rather than working from what the last plan did.

Documentation that supports the claim

An audit of D9612 goes to the medication log first, because that is the only record that proves the count. For each administration, capture five things:

• The drug, by name. Distinct names are what make the code correct, so a note reading “steroid and antibiotic given” does not do the job.
• The dose, with units.
• The route, whether intramuscular, intravenous, subcutaneous, submucosal, intraosseous, or intranasal.
• The site of the injection.
• The time it was given.

Two complete entries with two different drug names is the evidence that turns D9612 from an assertion into a documented fact. One entry, or two entries naming the same drug, and the claim will not survive review.

Add the clinical reason on top of the log. Name the condition being treated, the infection, the swelling, the nausea, and the circumstance that made the drugs necessary at that appointment. Keep it specific to the patient. A narrative reused verbatim across every therapeutic drug claim is easy to spot when a reviewer pulls a batch, and it undercuts the medical-necessity argument on all of them at once.

What to get right in your PMS

The menus differ across Open Dental, Dentrix, Eaglesoft, Curve, and Carestream, but the setup is the same in each:

1. Label the two codes by the count, not by the word “therapeutic.” Name them something like “therapeutic injection, one drug” and “therapeutic injection, two or more different drugs” in the code table. Two entries that both read “therapeutic parenteral drug” get picked by whichever is higher in the list.
2. Build a claim edit that blocks D9610 and D9612 on the same date. The pair is a known conflict, so catching it at posting is cheaper than working the denial.
3. Attach the medication log to the D9612 line, not just the chart. The count lives in that log, and a clearinghouse only sends what is attached to the claim. Practices that keep the log in a clinical note the biller never exports end up appealing with the evidence still sitting in the operatory.
4. Flag D9612 posted on a sedation date for review before it goes out. That combination is the one most likely to trigger a records request, and it usually means someone counted the sedation agents.
5. Record the benefit check for therapeutic drug administration in the patient’s insurance notes. Whether the plan covers the category at all, bundles it into same-day surgery, or excludes it outright decides the outcome long before documentation matters, and it saves the front desk from quoting the patient a number that will not hold.

For how these lines sit alongside the rest of a surgical claim, see the ADA dental claim form guide.